Location History:
- San Francisco, CA (US) (1995)
- Belmont, CA (US) (1998)
- Danville, CA (US) (1995 - 1999)
- San Ramon, CA (US) (2011 - 2021)
Company Filing History:
16 out of 130 
2 out of 313 
2 out of 3,222 
Years Active: 1995-2021
Title: The Innovations of David C. Cipolla: A Pioneer in Respiratory Treatment Formulations
Introduction
David C. Cipolla, located in San Ramon, CA, is a prominent inventor with a remarkable portfolio consisting of 21 patents. His innovative work primarily focuses on developing effective treatments for respiratory infections, particularly through the use of liposomal formulations.
Latest Patents
Among his latest contributions to the field are two significant patents. The first is titled "Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria - Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin." This patent describes specific liposome formulations and their delivery methods for treating respiratory tract infections and various medical conditions. The second patent, titled "Concentrated, inhalable ciprofloxacin formulation," discloses a concentrated inhalable formulation of ciprofloxacin that incorporates sodium acetate and liposome. This innovative formulation can be aerosolized and inhaled to effectively treat respiratory tract infections and other related medical conditions.
Career Highlights
Throughout his career, David has made significant contributions while working with notable companies such as Aradigm Corporation and Oregon State University. His expertise in pharmaceutical formulations has been instrumental in advancing treatment methodologies for severe respiratory infections.
Collaborations
David has collaborated with distinguished professionals in his field, including James Blanchard and Igor Gonda. These collaborations have enhanced the innovation ecosystem, propelling advancements in antibiotic delivery systems and treatment strategies.
Conclusion
David C. Cipolla stands as a noteworthy inventor whose contributions to respiratory treatment formulations have significantly impacted medical technology. With a total of 21 patents, his creative spirit and dedication to innovation continue to drive progress in the fight against respiratory infections. His work exemplifies how targeted inventions can lead to substantial advancements in healthcare.